RPID Q3 rev $7.6M (+24%), gross margin turns positive; director resigns

RAPID MICRO BIOSYSTEMS, INC.

2024-Q3 EPS reported -$0.86 revenue$19,833,000

Revenue $7.6M (+24% YoY); seven Growth Direct placements; gross margin positive 8% vs -27% last year.
Net loss $11.3M ($0.26/sh) vs $13.4M ($0.31) prior year.
Reaffirms FY2024 revenue guidance ≥$27.0M and ≥20 system placements.
David Hirsch resigns from board effective Nov 1; not due to disagreement, served since 2013.

item 2.02 item 5.02 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

David Hirsch

director

RPID · RAPID MICRO BIOSYSTEMS, INC.

Effective: 2024-11-01
Filed: November 1, 2024, 7:59 PM ET

On October 29, 2024, David Hirsch, M.D., Ph.D., notified the Company of his resignation from the board of directors of the Company and all committees thereof, effective as of November 1, 2024.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 1.0

David Hirsch resigned as director at RAPID MICRO BIOSYSTEMS, INC..

Action: resigned
Role: director

Exact text from the filing

On October 29, 2024, David Hirsch, M.D., Ph.D., notified the Company of his resignation from the board of directors of the Company and all committees thereof, effective as of November 1, 2024.

View on SEC.gov

RAPID MICRO BIOSYSTEMS, INC. filing history →

Source: SEC EDGAR

accession 0001380106-24-000191

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.